Haemoglobinopathies

Haemoglobinopathies: Early Detection and Treatment

Haemoglobinopathies are a group of disorders characterized by the production of abnormal hemoglobin in the blood. Globally, it is estimated that around 7% of the population may carry a clinically significant hemoglobinopathy. The most common conditions in this category include Sickle Cell Disease, Thalassemia, and Hemoglobin Traits.

Sickle Cell Disease is an inherited condition that affects the normal circulation of blood cells, potentially leading to severe pain episodes and damage to vital organs. Early detection and timely intervention are crucial in minimizing complications and improving the quality of life for affected children.

Early Diagnosis Saves Lives

Detecting haemoglobinopathies early can significantly reduce the risks associated with these disorders. Many conditions, if identified promptly, can be managed effectively with proper medical care and interventions.

Test Results and Follow-Up

Test results are typically available within a few days, sometimes taking up to five days. If the test indicates the presence of a haemoglobinopathy, parents will be contacted immediately. The doctor may recommend repeat or additional tests to confirm the diagnosis.

Next Steps for Positive Results

In cases where the results are positive, a consultant pediatrician will guide the necessary treatment and interventions tailored for your child’s health. Early medical care can help prevent severe complications and ensure better long-term outcomes.

Protect Your Child’s Health

Routine screening for haemoglobinopathies is a vital step in safeguarding your child’s health. Early detection and intervention provide the best chance for managing these conditions effectively and improving overall well-being.

Coming Soon!

Trusted Screening Powered by Science

Ugene Labs Pvt Ltd. is a leading provider of advanced prenatal and newborn genetic screening, committed to ensuring healthier beginnings for every child.